中国医学创新2024,Vol.21Issue(36) :185-188.DOI:10.3969/j.issn.1674-4985.2024.36.043

前列腺癌诊断技术的研究进展

Research Progress of Diagnostic Techniques for Prostate Cancer

邱亚 王薇
中国医学创新2024,Vol.21Issue(36) :185-188.DOI:10.3969/j.issn.1674-4985.2024.36.043

前列腺癌诊断技术的研究进展

Research Progress of Diagnostic Techniques for Prostate Cancer

邱亚 1王薇2
扫码查看

作者信息

  • 1. 佳木斯大学临床医学院 黑龙江 佳木斯 154007
  • 2. 佳木斯大学附属第一医院超声医学科 黑龙江 佳木斯 154000
  • 折叠

摘要

前列腺癌(prostate cancer,PCa)是全世界第二常见的男性恶性肿瘤疾病,近年来,我国PCa的发病率明显升高.目前针对PCa的诊断主要依赖于直肠指诊(digital rectal examination,DRE)、前列腺特异性抗原(prostate-specific antigen,PSA)检测、经直肠超声检查(transrectal ultrasonography,TRUS)、多参数磁共振成像(multi-parametric magnetic resonance imaging,mp-MRI),单一诊断方式存在局限性,经直肠超声引导下的穿刺活检是目前诊断前列腺癌的金标准.本文主要回顾了PCa领域中不同诊断技术的现有研究,并探讨了新的成像方式在未来的应用潜力,旨在为前列腺癌患者的早期诊断、临床治疗及改善预后提供更准确、全面的信息.

Abstract

Prostate cancer (PCa) is the second most common male malignant tumor disease in the world,and the incidence of PCa has increased significantly in China in recent years.At present,the diagnosis of PCa mainly depends on digital rectal examination (DRE),prostate-specific antigen (PSA) detection,transrectal ultrasonography (TRUS),multi-parametric magnetic resonance imaging (mp-MRI).Single diagnosis method has limitations.Transrectal ultrasound-guided puncture biopsy is the gold standard for the diagnosis of PCa at present.This article mainly reviews the existing research on different diagnostic techniques in the field of PCa,and discusses the potential application of new imaging methods in the future,aiming to provide more accurate and comprehensive information for the early diagnosis,clinical treatment and improvement of prognosis of patients with PCa.

关键词

前列腺癌/经直肠超声检查/前列腺特异性抗原

Key words

Prostate cancer/Transrectal ultrasonography/Prostate-specific antigen

引用本文复制引用

出版年

2024
中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
段落导航相关论文